LENUREX-K

This brand name is authorized in South Africa

Active ingredients

The drug LENUREX-K contains a combination of these active pharmaceutical ingredients (APIs):

1 Cyclopenthiazide
UNII VX4S2N85F5 - CYCLOPENTHIAZIDE
Read about Cyclopenthiazide
2 Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.

Read about Potassium chloride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C03AB07 Cyclopenthiazide and potassium C Cardiovascular system → C03 Diuretics → C03A Low-ceiling diuretics, thiazides → C03AB Thiazides and potassium in combination
Discover more medicines within C03AB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ZA Health Products Regulatory Authority Identifier(s): L/18.1/418

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈